The Department of Pharmaceuticals (DoP) has moved a Cabinet note on bulk drugs based on the recommendations of Katoch committee, Fertiliser Minister Ananth Kumar said today.
Bulk drugs are used as raw materials by the pharmaceutical industry.
"We have moved a Cabinet note on the basis of Katoch committee recommendations and at present it is under discussion," Kumar said.
He was speaking after releasing a report on recommendations to develop manufacturing capabilities in pharmaceutical sector.
The minister added that the new draft policy will raise the domestic output of bulk drugs in the country as well as bring down the imports.
India meets about 80 per cent of its demand of bulk drugs through import from China.
The government had set up a committee headed by V M Katoch, Secretary, Health Research, to suggest ways to reduce the dependence on bulk drug imports from China.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
